Medirom Debt To Assets from 2010 to 2024

MRM Stock  USD 2.64  0.06  2.22%   
Medirom Healthcare Debt To Assets yearly trend continues to be very stable with very little volatility. Debt To Assets are likely to drop to 0.14. During the period from 2010 to 2024, Medirom Healthcare Debt To Assets quarterly data regression pattern had sample variance of  0.0006 and median of  0.17. View All Fundamentals
 
Debt To Assets  
First Reported
2010-12-31
Previous Quarter
0.22648185
Current Value
0.14
Quarterly Volatility
0.02388185
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Medirom Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medirom Healthcare's main balance sheet or income statement drivers, such as Interest Income of 2 M, Depreciation And Amortization of 135.8 M or Interest Expense of 18.5 M, as well as many indicators such as Price To Sales Ratio of 0.58, Dividend Yield of 0.0 or PTB Ratio of 20.74. Medirom financial statements analysis is a perfect complement when working with Medirom Healthcare Valuation or Volatility modules.
  
Check out the analysis of Medirom Healthcare Correlation against competitors.

Latest Medirom Healthcare's Debt To Assets Growth Pattern

Below is the plot of the Debt To Assets of Medirom Healthcare Technologies over the last few years. It is Medirom Healthcare's Debt To Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Medirom Healthcare's overall financial position and show how it may be relating to other accounts over time.
Debt To Assets10 Years Trend
Very volatile
   Debt To Assets   
       Timeline  

Medirom Debt To Assets Regression Statistics

Arithmetic Mean0.17
Geometric Mean0.16
Coefficient Of Variation14.42
Mean Deviation0.01
Median0.17
Standard Deviation0.02
Sample Variance0.0006
Range0.1167
R-Value0.05
Mean Square Error0.0006
R-Squared0
Significance0.86
Slope0.0003
Total Sum of Squares0.01

Medirom Debt To Assets History

2024 0.14
2023 0.23
2022 0.19
2020 0.16
2019 0.11

About Medirom Healthcare Financial Statements

Medirom Healthcare investors utilize fundamental indicators, such as Debt To Assets, to predict how Medirom Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Debt To Assets 0.23  0.14 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Medirom Healthcare is a strong investment it is important to analyze Medirom Healthcare's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Medirom Healthcare's future performance. For an informed investment choice regarding Medirom Stock, refer to the following important reports:
Check out the analysis of Medirom Healthcare Correlation against competitors.
You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medirom Healthcare. If investors know Medirom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medirom Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.582
Earnings Share
(0.15)
Revenue Per Share
1.4 K
Quarterly Revenue Growth
(0.06)
Return On Assets
(0.04)
The market value of Medirom Healthcare is measured differently than its book value, which is the value of Medirom that is recorded on the company's balance sheet. Investors also form their own opinion of Medirom Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Medirom Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medirom Healthcare's market value can be influenced by many factors that don't directly affect Medirom Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medirom Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medirom Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medirom Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.